Evidence map›Paper›PMID 28453568›Full record

ArticlePloS one2017

Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.

Jing Luo, Biying Dong, Ke Wang, Shuangqi Cai, Tangjuan Liu, Xiaojing Cheng, Danqing Lei, Yanling Chen, Yanan Li, Jinliang Kong and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed, 2 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 2 syntheses or guidelines pooled it, 310 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. The dual role of the microbiome in chronic wound management.Cell communication and signaling : CCS · 2026
    Review
  11. Harnessing the Antimicrobial Potential of Baicalein-Coated FeACS applied materials & interfaces · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Isolation and Identification ofVeterinary medicine international · 2026
    Article
  18. Review
  19. Review
  20. Article

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jing LuoDepartment of Respiratory Disease, First Affiliated Hospital of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.ORCID http://orcid.org/0000-0002-8186-4745
Biying DongDepartment of Respiratory Disease, First Affiliated Hospital of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Ke WangDepartment of Respiratory Disease, First Affiliated Hospital of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Shuangqi CaiDepartment of Respiratory Disease, First Affiliated Hospital of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Tangjuan LiuDepartment of Respiratory Disease, First Affiliated Hospital of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Xiaojing ChengLife Sciences Institute of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Danqing LeiLife Sciences Institute of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Yanling ChenDepartment of Respiratory Disease, First Affiliated Hospital of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Yanan LiDepartment of Respiratory Disease, First Affiliated Hospital of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Jinliang KongDepartment of Respiratory Disease, First Affiliated Hospital of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Yiqiang ChenDepartment of Respiratory Disease, First Affiliated Hospital of Guangxi Medical University, Qingxiu, Nanning, Guangxi, People's Republic of China.
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quorum sensing (QS) circuit plays a role in the precise regulation of genes controlling virulence factors and biofilm formation in Pseudomonas aeruginosa. QS-controlled biofilm formation by Pseudomonas aeruginosa in clinical settings has remained controversial due to emerging drug resistance; therefore, screening diverse compounds for anti-biofilm or anti-QS activities is important. This study demonstrates the ability of sub-minimum inhibitory concentrations (sub-MICs) of baicalin, an active natural compound extracted from the traditional Chinese medicinal Scutellaria baicalensis, to inhibit the formation of Pseudomonas aeruginosa biofilms and enhance the bactericidal effects of various conventional antibiotics in vitro. In addition, baicalin exerted dose-dependent inhibitory effects on virulence phenotypes (LasA protease, LasB elastase, pyocyanin, rhamnolipid, motilities and exotoxin A) regulated by QS in Pseudomonas aeruginosa. Moreover, the expression levels of QS-regulatory genes, including lasI, lasR, rhlI, rhlR, pqsR and pqsA, were repressed after sub-MIC baicalin treatment, resulting in significant decreases in the QS signaling molecules 3-oxo-C12-HSL and C4-HSL, confirming the ability of baicalin-mediated QS inhibition to alter gene and protein expression. In vivo experiments indicated that baicalin treatment reduces Pseudomonas aeruginosa pathogenicity in Caenorhabditis elegans. Greater worm survival in the baicalin-treated group manifested as an increase in the LT50 from 24 to 96 h. In a mouse peritoneal implant infection model, baicalin treatment enhanced the clearance of Pseudomonas aeruginosa from the implants of mice infected with Pseudomonas aeruginosa compared with the control group. Moreover, the combination of baicalin and antibiotics significantly reduced the numbers of colony-forming units in the implants to a significantly greater degree than antibiotic treatment alone. Pathological and histological analyses revealed mitigation of the inflammatory response and reduced cell infiltration in the peritoneal tissue surrounding the implants after baicalin treatment. Measurement of the cytokine levels in the peritoneal lavage fluid of mice in the baicalin treatment group revealed a decrease in IL-4, an increase in interferon γ (IFN-γ), and a reversed IFN-γ/IL-4 ratio compared with the control group, indicating that baicalin treatment activated the Th1-induced immune response to expedite bacterial load clearance. Based on these results, baicalin might be a potent QS inhibitor and anti-biofilm agent for combating Pseudomonas aeruginosa biofilm-related infections.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial ProteinsBiofilmsCaenorhabditis elegansDisease Models, AnimalDose-Response Relationship, DrugDrug Therapy, CombinationFemaleFlavonoidsInterferon-gammaInterleukin-4Mice, Inbred BALB CPeritoneumProstheses and ImplantsProsthesis-Related InfectionsAnti-Bacterial AgentsBacterial ProteinsbaicalinFlavonoidsInterferon-gammaInterleukin-4Virulence Factors

Identifiers

PMID28453568
PMCPMC5409170
OpenAlexW2609591691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.